Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer

Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page

  1. Check
    7 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates to terminology for artificial intelligence during a transition. The clinical study record itself remains inaccessible and displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:35:42.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:47:09.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:14:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error in place of the study record for sacituzumab govitecan in adults with epithelial cancer.
    Difference
    22%
    Check dated 2026-10-04T16:05:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 error instead of the study record content, replacing the detailed study information and navigation with a generic error page.
    Difference
    22%
    Check dated 2026-09-20T19:53:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous v3.6.5 in the page footer. It indicates a minor platform update and does not change the study details on the page.
    Difference
    0.0%
    Check dated 2026-08-30T16:05:39.000Z thumbnail image

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer

Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.